Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Drugs Ltd has informed BSE that its trading window for dealing in securities will be closed from January 1, 2026, until 48 hours after the announcement of unaudited financial results for the quarter ending December 31, 2025. During this period, all directors, designated employees, insiders, and their immediate relatives are prohibited from trading in the company's shares. The trading window will reopen 48 hours after the Q3 FY26 results are declared. The date of the board meeting to approve these results will be communicated separately.
This is a routine compliance disclosure under SEBI insider trading rules and is typically neutral for the stock. However, it signals that Q3 FY26 earnings are expected soon, which may draw investor attention once results are announced.